Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients

BACKGROUND: The health care industry is witnessing an increasing trend in the use of generic medicines because of their presumed low cost compared with innovator medicines. The aim of this study was to determine and compare the performance of the copy drug Osveral(®) and its innovator drug deferasir...

Descripción completa

Detalles Bibliográficos
Autores principales: Daher, Aqil M., Al-Momen, Hayder, Jasim, Shaymaa Kadhim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785916/
https://www.ncbi.nlm.nih.gov/pubmed/31636883
http://dx.doi.org/10.1177/2042098619880123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785916/
https://www.ncbi.nlm.nih.gov/pubmed/31636883
http://dx.doi.org/10.1177/2042098619880123

Ejemplares similares